Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Recruiting · NCT07421739 · Observational (researchers observe without assigning treatment) · Lead sponsor: Aura Biosciences
View the official record on ClinicalTrials.gov →Interventions studied
Non-interventional, digital, patient-reported, real-world study
What this trial is about
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Have enrolled in the Aura-sponsored clinical trial AU-011-301.
- Access to a connected device (i.e., smartphone, laptop, or tablet)
Exclusion criteria
- None
Where it is running
1 location listed.
- Eye Research Australia - East Melbourne, Victoria, Australia